Elena is Associate Director of Scientific Programs at the AACR, where she supports the development of high‑impact scientific content and strategic programming for the AACR Annual Meeting. Previously, she was a Research Assistant Professor and Co‑Director of the TRACES Core Facility at Drexel University, advancing work at the interface of molecular biology and translational science. She holds a PharmD from the University Federico II of Naples and a PhD from the University of Erlangen-Nuremberg, and completed postdoctoral training in the United States. Her interdisciplinary background—spanning cancer biology, neuroscience, and pharmacology—reflects a commitment to translating fundamental discoveries into clinical impact.

Emanuele is a physician-scientist currently working at GlaxoSmithKline (GSK) as Clinical Development Director for Respiratory, Immunology & Inflammation. Bridging translational research with global strategy, his work focuses on advancing complex therapeutic pipelines. His foundational training and primary academic research reside in immunology, medical microbiology, with specific, high-impact expertise in the human microbiome's systemic influence on osteoarthritis (OA) and the pathogenesis of periprosthetic joint infections (PJI).

Assistant Professor in Pediatrics & Bioengineering at the University of Pennsylvania and Children's Hospital of Philadelphia. He graduated from the University of Genova and then pursued postgraduate studies at the University of Pittsburgh. He leads the Bioengineering and Biomaterials (Bio2) lab, collaborating on clinical and research efforts to offer engineering solutions for pediatric health, primarily treatments for airway disorders.

Laura earned her PhD in 2010 from the University of Palermo, Italy, in collaboration with Temple University in Philadelphia. She conducted translational and preclinical cancer research at Temple University, Thomas Jefferson University, the Children’s Hospital of Philadelphia, and the University of Pennsylvania, focusing on drug development, targeted therapies, and treatment resistance across multiple cancers.
In 2022, she joined the American Association for Cancer Research (AACR) as Assistant Director in the Executive Office of Scientific Programs and Scientific Initiatives, where she supports the development of high-impact research initiatives in cancer prevention and hematologic malignancies.

Alessandra is Head of Sales for North America and Canada at Immudex, where she leads a four-person team and drives go-to-market strategy for immune-monitoring reagents across academic, biotech, and pharma partners. She previously held commercial leadership roles at Champions Oncology, securing multimillion-dollar partnerships in biomarker development and clinical trials. She completed postdoctoral training at MD Anderson Cancer Center, earned her PhD in Stem Cell Biology from University College London after studying biotechnology at the University of Padua, and later an Executive MBA from the Quantic School of Business and Technology. Her career spans oncology research and life science commercial leadership, focused on advancing innovation in immunology and drug development.